X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (132) 132
male (126) 126
female (101) 101
adult (80) 80
middle aged (78) 78
index medicus (58) 58
gastroenterology & hepatology (52) 52
aged (49) 49
animals (43) 43
liver (33) 33
pharmacology & pharmacy (32) 32
liver - pathology (25) 25
rats (25) 25
cirrhosis (24) 24
medicine, research & experimental (24) 24
treatment outcome (23) 23
rats, wistar (21) 21
drug therapy, combination (20) 20
mice (19) 19
adolescent (18) 18
gastroenterology and hepatology (18) 18
hepatitis (18) 18
time factors (18) 18
antiviral agents - therapeutic use (17) 17
genotype (17) 17
hepatitis c (17) 17
transplantation (17) 17
expression (16) 16
hepatitis c virus (16) 16
hepatitis c, chronic - drug therapy (16) 16
hepacivirus - genetics (15) 15
activation (14) 14
aged, 80 and over (14) 14
analysis (14) 14
disease (14) 14
liver transplantation (14) 14
hepatocytes (13) 13
immunohistochemistry (13) 13
liver - metabolism (13) 13
liver cirrhosis (13) 13
liver diseases (13) 13
antiviral agents - adverse effects (12) 12
dose-response relationship, drug (12) 12
infection (12) 12
risk factors (12) 12
severity of illness index (12) 12
surgery (12) 12
liver - drug effects (11) 11
liver regeneration (11) 11
radiology, nuclear medicine & medical imaging (11) 11
toxicology (11) 11
biopsy (10) 10
cytochrome p-450 enzyme system - metabolism (10) 10
fibrosis (10) 10
inflammation (10) 10
interferon (10) 10
metabolism (10) 10
nonalcoholic steatohepatitis (10) 10
ribavirin (10) 10
ribavirin - therapeutic use (10) 10
young adult (10) 10
apoptosis (9) 9
care and treatment (9) 9
fatty liver - pathology (9) 9
follow-up studies (9) 9
health aspects (9) 9
pathology (9) 9
rat (9) 9
research (9) 9
retrospective studies (9) 9
abridged index medicus (8) 8
antiviral agents - administration & dosage (8) 8
biological response modifiers (8) 8
cancer (8) 8
chronic hepatitis-c (8) 8
cytochrome p-450 cyp3a (8) 8
disease models, animal (8) 8
drug therapy (8) 8
enzymes (8) 8
fatty liver - metabolism (8) 8
immunology (8) 8
magnetic resonance imaging (8) 8
medicine, general & internal (8) 8
prospective studies (8) 8
rna, viral - blood (8) 8
virus-infection (8) 8
alanine transaminase - blood (7) 7
area under curve (7) 7
aryl hydrocarbon hydroxylases (7) 7
blotting, western (7) 7
genetic aspects (7) 7
hepatectomy (7) 7
hepatology (7) 7
induction (7) 7
infections (7) 7
liver - blood supply (7) 7
liver - enzymology (7) 7
liver cirrhosis - physiopathology (7) 7
liver fibrosis (7) 7
liver function tests (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2014, Volume 384, Issue 9941, pp. 414 - 426
Journal Article
Journal of Oncology Pharmacy Practice, ISSN 1078-1552, 2018, p. 107815521881974
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 386, Issue 10003, pp. 1514 - 1515
Journal Article
The Lancet Infectious Diseases, ISSN 1473-3099, 10/2017, Volume 17, Issue 10, pp. 1062 - 1068
Journal Article
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 12/2018, p. 1078155218819742
A 68-year-old man develops acute hepatocellular injury during treatment with direct-acting antiviral agents (DAA) for hepatitis C. Medical history reveals the... 
Journal Article
American Journal of Physiology - Gastrointestinal and Liver Physiology, ISSN 0193-1857, 01/2010, Volume 298, Issue 1, pp. 107 - 116
Journal Article
Journal Article
Journal Article
Drug Safety, ISSN 0114-5916, 3/2011, Volume 34, Issue 3, pp. 243 - 252
Journal Article
Gastroenterology, ISSN 0016-5085, 2014, Volume 147, Issue 2, pp. 359 - 365.e1
Background & Aims The interferon-free regimen of ABT-450 (a protease inhibitor), ritonavir, ombitasvir (an NS5A inhibitor), dasabuvir (a non-nucleoside... 
Gastroenterology and Hepatology | IFN | PEARL-II | Ribavirin-Free | Interferon-Free Therapy | PLUS RIBAVIRIN | ABT-450/R-OMBITASVIR | VIRUS-INFECTION | TELAPREVIR | SOFOSBUVIR | CHRONIC HEPATITIS-C | COMBINATION | TRIAL | CIRRHOSIS | BOCEPREVIR | GASTROENTEROLOGY & HEPATOLOGY | Anilides - therapeutic use | Puerto Rico | Hepatitis C - drug therapy | United States | Anilides - adverse effects | Humans | Middle Aged | Hepacivirus - genetics | Male | RNA, Viral - blood | Viral Load | Ritonavir - adverse effects | Time Factors | Ritonavir - therapeutic use | Adult | Female | Drug Therapy, Combination | Hepacivirus - drug effects | Antiviral Agents - therapeutic use | Europe | Ribavirin - therapeutic use | Uracil - therapeutic use | Genotype | Treatment Outcome | Macrocyclic Compounds - adverse effects | Biomarkers - blood | Macrocyclic Compounds - therapeutic use | Hepatitis C - diagnosis | Uracil - adverse effects | Sulfonamides - therapeutic use | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Sulfonamides - adverse effects | Carbamates - adverse effects | Hepacivirus - growth & development | Aged | Carbamates - therapeutic use | Uracil - analogs & derivatives | Medical colleges | Care and treatment | Proteases | Ritonavir | Biological products industry | Genetic aspects | Biological response modifiers | Hepatitis C virus | Hepatitis C | Health aspects | Ribavirin
Journal Article
Journal of Public Health, ISSN 2198-1833, 10/2018, Volume 26, Issue 5, pp. 595 - 603
The Democratic Republic of Congo (DRC) is a country with a high endemicity of hepatitis B virus (HBV) even if no national survey of prevalence has been... 
Public Health | Prevalence | Medicine & Public Health | DRC | Health Promotion and Disease Prevention | Hepatitis B virus | Review | Epidemiology | Hepatitis B surface antigen | Viruses | Infections | Disease control | Blood | Blood donors | Confidence intervals | Pregnancy | Hepatitis | Reviews | Donors (electronic) | Public health | Hepatitis B
Journal Article